相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Brain Pathology in Mucopolysaccharidoses (MPS) Patients with Neurological Forms
Gustavo M. Viana et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Cysteine cathepsins as therapeutic targets in inflammatory diseases
Matej Vizovisek et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2020)
Regulation of the Proteolytic Activity of Cysteine Cathepsins by Oxidants
Gilles Lalmanach et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cathepsins in the Pathophysiology of Mucopolysaccharidoses: New Perspectives for Therapy
Valeria De Pasquale et al.
CELLS (2020)
Cysteine cathepsins in extracellular matrix remodeling: Extracellular matrix degradation and beyond
Matej Vizovisek et al.
MATRIX BIOLOGY (2019)
Cysteine Cathepsins and Their Extracellular Roles: Shaping the Microenvironment
Eva Vidak et al.
CELLS (2019)
Heparan sulfate proteoglycans: The sweet side of development turns sour in mucopolysaccharidoses
Valeria De Pasquale et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2019)
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice
Esteban Alberto Gonzalez et al.
LIFE SCIENCES (2018)
Extracellular matrix: The driving force of mammalian diseases
Renato V. Iozzo et al.
MATRIX BIOLOGY (2018)
Clinical presentation and diagnosis of mucopolysaccharidoses
Molly Stapleton et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Targeting Heparan Sulfate Proteoglycans as a Novel Therapeutic Strategy for Mucopolysaccharidoses
Valeria De Pasquale et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Substrate accumulation and extracellular matrix remodelling promote persistent upper airway disease in mucopolysaccharidosis patients on enzyme replacement therapy
Abhijit Ricky Pal et al.
PLOS ONE (2018)
Enzyme replacement therapy: efficacy and limitations
Daniela Concolino et al.
ITALIAN JOURNAL OF PEDIATRICS (2018)
A current view of perlecan in physiology and pathology: A mosaic of functions
Maria A. Gubbiotti et al.
MATRIX BIOLOGY (2017)
The Future of Cysteine Cathepsins in Disease Management
Lovro Kramer et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity
Guilherme Baldo et al.
CARDIOVASCULAR PATHOLOGY (2017)
Computational analysis of interactions in structurally available protein-glycosaminoglycan complexes
Sergey A. Samsonov et al.
GLYCOBIOLOGY (2016)
Severe tracheal and bronchial collapse in adults with type II mucopolysaccharidosis
M. Rutten et al.
ORPHANET JOURNAL OF RARE DISEASES (2016)
Airway-Related Symptoms and Surgeries in Patients With Mucopolysaccharidosis I
Pamela Am et al.
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2015)
Cysteine Cathepsin Activity Regulation by Glycosaminoglycans
Marko Novinec et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Binding of Chondroitin 4-Sulfate to Cathepsin S Regulates Its Enzymatic Activity
Juliette Sage et al.
BIOCHEMISTRY (2013)
Extracellular matrix components: An intricate network of possible biomarkers for lysosomal storage disorders?
Spyros P. Batzios et al.
FEBS LETTERS (2013)
Elastin Degradation by Cathepsin V Requires Two Exosites
Xin Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Respiratory and sleep disorders in mucopolysaccharidosis
Kenneth I. Berger et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2013)
Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling
Annelie Pichert et al.
GLYCOBIOLOGY (2012)
Respiratory Manifestations in Mucopolysaccharidoses
Marianne S. Muhlebach et al.
PAEDIATRIC RESPIRATORY REVIEWS (2011)
Human Cysteine Cathepsins Are Not Reliable Markers of Infection by Pseudomonas aeruginosa in Cystic Fibrosis
Clement Naudin et al.
PLOS ONE (2011)
Lack of cathepsin activities alter or prevent the development of lung granulomas in a mouse model of sarcoidosis
Andriy O. Samokhin et al.
RESPIRATORY RESEARCH (2011)
Chemoenzymatic Design of Heparan Sulfate Oligosaccharides
Renpeng Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Specialized roles for cysteine cathepsins in health and disease
Jochen Reiser et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Glycosaminoglycan-Mediated Loss of Cathepsin K Collagenolytic Activity in MPS I Contributes to Osteoclast and Growth Plate Abnormalities
Susan Wilson et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Surfen, a small molecule antagonist of heparan sulfate
Manuela Schuksz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
GLYCAM06: A generalizable Biomolecular force field. Carbohydrates
Karl N. Kirschner et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2008)
Cell type-specific functions of the lysosomal protease cathepsin L in the heart
Daniel Spira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Effect of neonatal administration of a retroviral vector expressing α-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I mice
Sarah Chung et al.
MOLECULAR GENETICS AND METABOLISM (2007)
Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells
CD Pan et al.
BLOOD (2005)
Heparan sulfate: A complex polymer charged with biological activity
JM Whitelock et al.
CHEMICAL REVIEWS (2005)
Glycosaminoglycan degradation fragments in mucopolysaccharidosis I
M Fuller et al.
GLYCOBIOLOGY (2004)
Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages
Y Yasuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Improved and simple micro assay for sulfated glycosaminoglycans quantification in biological extracts and its use in skin and muscle tissue studies
I Barbosa et al.
GLYCOBIOLOGY (2003)
Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis
E Tolosa et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB
K Ohmi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Human and parasitic papain-like cysteine proteases:: Their role in physiology and pathology and recent developments in inhibitor design
F Lecaille et al.
CHEMICAL REVIEWS (2002)
Design of noncovalent inhibitors of human cathepsin L.: From the 96-residue proregion to optimized tripeptides
SF Chowdhury et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Effective Born radii in the generalized Born approximation: The importance of being perfect
A Onufriev et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2002)
Disordered breathing during sleep in patients with mucopolysaccharidoses
SEJ Leighton et al.
INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY (2001)
Collagenolytic activity of cathepsin K is specifically modulated by cartilage-resident chondroitin sulfates
ZQ Li et al.
BIOCHEMISTRY (2000)
分享论文
